Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KE YANG

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1316438328
CMS profile
10417403
Location
RALEIGH, NC

General Payments · PY2022–2024

$791.23

  • Reported across 40 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$314.69

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $314.69 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $76.57 4
Abbott Laboratories $54.05 3
Janssen Pharmaceuticals, Inc $45.14 2
ABBVIE INC. $38.64 2
Lilly USA, LLC $35.66 2
Otsuka America Pharmaceutical, Inc. $27.89 1
PFIZER INC. $23.30 1
Acerta Pharma LLC $13.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $200.34 10
PY2023 $276.20 14
PY2024 $314.69 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $22.67 02/18/2024 Food and Beverage Undisputed 01/23/2026 1124985463 CMS
Abbott Laboratories $13.58 05/15/2024 Food and Beverage Undisputed 01/23/2026 1124985468 CMS
Abbott Laboratories $17.80 06/19/2024 Food and Beverage Undisputed 01/23/2026 1124985471 CMS
ABBVIE INC. $19.92 01/05/2024 Food and Beverage Undisputed 01/23/2026 1108446325 CMS
ABBVIE INC. $18.72 07/23/2024 Food and Beverage Undisputed 01/23/2026 1108446327 CMS
AstraZeneca Pharmaceuticals LP $13.44 04/19/2024 Food and Beverage Undisputed 01/23/2026 1105773610 CMS
Janssen Pharmaceuticals, Inc $17.76 04/02/2024 Food and Beverage Undisputed 01/23/2026 1078081394 CMS
Janssen Pharmaceuticals, Inc $27.38 07/02/2024 Food and Beverage Undisputed 01/23/2026 1078081362 CMS
Lilly USA, LLC $20.26 01/16/2024 Food and Beverage Undisputed 01/23/2026 1135766959 CMS
Lilly USA, LLC $15.40 10/08/2024 Food and Beverage Undisputed 01/23/2026 1135759678 CMS
Novo Nordisk Inc $22.62 02/27/2024 Food and Beverage Undisputed 01/23/2026 1100583026 CMS
Novo Nordisk Inc $19.09 04/11/2024 Food and Beverage Undisputed 01/23/2026 1100402433 CMS
Novo Nordisk Inc $17.23 08/08/2024 Food and Beverage Undisputed 01/23/2026 1100432911 CMS
Novo Nordisk Inc $17.63 11/25/2024 Food and Beverage Undisputed 01/23/2026 1100444269 CMS
Otsuka America Pharmaceutical, Inc. $27.89 02/06/2024 Food and Beverage Undisputed 01/23/2026 1119218777 CMS
PFIZER INC. $23.30 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131863883 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.